Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Stock Price & Analysis
1762 Stock Chart & Stats
- Day’s Range
- TWD 29.25 - TWD 30.95
- 52-Week Range
- TWD 24.20 - TWD 44.75
- Previous Close
- TWD 30.70
- Volume
- N/A
- Average Volume (3M)
- 77.72K
- Market Cap
- TWD 2.38B
- Enterprise Value
- TWD 2.48B
- Total Cash (Recent Filing)
- TWD 329.96M
- Total Debt (Recent Filing)
- TWD 755.63M
- Price to Earnings (P/E)
- ―
- Beta
- 0.75
- Next Earnings
- Nov 16, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 24, 2025
- Dividend Yield
- 0.62%
1762 FAQ
What was Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s price range in the past 12 months?
What is Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s market cap?
When is Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s upcoming earnings report date?
How were Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s earnings last quarter?
Is Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A overvalued?
Does Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A pay dividends?
What is Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s EPS estimate?
How many shares outstanding does Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A have?
What happened to Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A
Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.
- Sector
- General
- Industry
- Medical - Pharmaceuticals
- CEO
- Chung Hsin Huang
- Employees
- 243
- Website
- www.ccsb.com.tw
- Address
- No.1, Dongxing Street, New Taipei City, TP, 23850, TW
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

